Melatonin evidence, 2001

Zhdanova IV, Wurtman RJ, et al., Journal of Clinical Endocrinology & Metabolism, 2001 — crossover RCT of 0.1–3 mg melatonin in older adults

Grade
Design
crossover rct
Year
2001
Participants
30
Ingredient
Melatonin
Goal
Sleep

Effect

Doses as low as 0.3 mg improved sleep efficiency comparably to 3 mg; higher doses produced more next-day carryover without better sleep.

Limitations and notes

Why our dose guidance starts at 0.5 mg rather than the retail default of 5–10 mg.

Cited by